| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $160.7M | — | +162.1% |
| Cost of Revenue | $128.5M | — | +173.2% |
| Gross Profit | $32.2M | — | +125.5% |
| R&D Expense | $5.0M | — | +53.8% |
| SG&A Expense | $32.4M | — | +115.8% |
| Operating Income | -$5.3M | — | -31.2% |
| Pre-tax Income | -$11.4M | — | -96.0% |
| Income Tax | -$284K | — | -174.0% |
| Net Income | -$12.3M | — | -67.6% |
| EPS (Basic) | -$0.25 | — | -66.7% |
| EPS (Diluted) | -$0.25 | — | -66.7% |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $22.2M | -4.3% | -56.6% |
| Accounts Receivable | $89.2M | -10.9% | +128.1% |
| Inventory | $25.6M | +4.0% | +79.8% |
| Current Assets | $182.1M | -5.8% | +21.1% |
| Total Assets | $732.9M | -0.1% | +124.3% |
| Current Liabilities | $354.1M |
| Line Item | 2026-03-29 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $27.9M | — | -50.1% |
| Capital Expenditures | $9.1M | — | -38.7% |
| Investing Cash Flow | -$10.1M | — | +33.5% |
| Financing Cash Flow | -$18.8M | — | -123.9% |
| Free Cash Flow | $18.9M | — | -54.2% |
| +178.1% |
| Long-term Debt | $37.5M | -3.5% | -2.9% |
| Total Liabilities | $545.0M | +1.3% | +103.9% |
| Stockholders' Equity | $180.2M | -4.0% | +237.5% |